These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11214617)

  • 21. Fine needle aspiration cytology in the management of palpable benign and malignant breast disease. Correlation with clinical and mammographic findings.
    Langmuir VK; Cramer SF; Hood ME
    Acta Cytol; 1989; 33(1):93-8. PubMed ID: 2916375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of the value of combined mammographic and sonographic assessment in patients with palpable abnormalities of the breast.
    Shetty MK; Shah YP; Sharman RS
    J Ultrasound Med; 2003 Mar; 22(3):263-8; quiz 269-70. PubMed ID: 12636326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
    Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
    World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions.
    Daldrup-Link HE; Kaiser A; Helbich T; Werner M; Bjørnerud A; Link TM; Rummeny EJ
    Acad Radiol; 2003 Nov; 10(11):1237-46. PubMed ID: 14626298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical assessment of benign breast disease in screening.
    Monypenny IJ
    Br J Clin Pract Suppl; 1989 Nov; 68():118-20; discussion 133-6. PubMed ID: 2488553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of support vector machine-recursive feature elimination algorithm in Raman spectroscopy for differential diagnosis of benign and malignant breast diseases].
    Zhang H; Fu T; Zhang Z; Fan Z; Zheng C; Han B
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):582-6. PubMed ID: 25430023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving strategies for the management of non-palpable breast abnormalities.
    Kurtzman SH; MacGillivray DC; Deckers PJ
    Surg Oncol; 1995 Feb; 4(1):1-14. PubMed ID: 7780607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphometric analysis of fine needle aspirates from breast lesions.
    Mapstone NP; Zakhour HD
    Cytopathology; 1990; 1(6):349-55. PubMed ID: 2101681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stereotactic core biopsy of breast microcalcifications. Aid to diagnosis?].
    Chopier J; Seror JY; Antoine M; Sananes S; Merviel P; Amram S; Uzan S; Bigot JM
    J Radiol; 1997 Nov; 78(11):1141-6. PubMed ID: 9499951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of ductal obstruction sign in the differentiation of benign and malignant breast lesions at MR imaging.
    Baltzer PA; Kaiser CG; Dietzel M; Vag T; Herzog AB; Gajda M; Camara O; Kaiser WA
    Eur J Radiol; 2010 Aug; 75(2):e18-21. PubMed ID: 19954911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
    Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
    Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic framework of nonpalpable lesions of the breast].
    Ciatto S; Rosselli Del Turco M
    Chir Ital; 1995; 47(4):5-8. PubMed ID: 9005133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medullary carcinoma of the breast: a malignant lesion mimicking a benign one].
    Lorente Ramos RM; del Valle Sanz Y; Alcaraz Mexía MJ; Jareño Dorrego E
    Radiologia; 2006; 48(3):165-8. PubMed ID: 17058639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign breast lesions that simulate malignancy: magnetic resonance imaging with radiologic-pathologic correlation.
    Iglesias A; Arias M; Santiago P; Rodríguez M; Mañas J; Saborido C
    Curr Probl Diagn Radiol; 2007; 36(2):66-82. PubMed ID: 17331838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
    Lee JK; Kao CH; Sun SS
    Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign lesions that mimic malignant tumors.
    Semin Diagn Pathol; 1990 May; 7(2):89-155. PubMed ID: 2362974
    [No Abstract]   [Full Text] [Related]  

  • 37. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred?
    Park YM; Kim EK; Lee JH; Ryu JH; Han SS; Choi SJ; Lee SJ; Yoon HK
    Acta Radiol; 2008 Dec; 49(10):1104-11. PubMed ID: 18855166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomagnetic activity in the female breast at various physiological states.
    Sivridis E; Anninos P; Giatromanolaki A; Kotini A; Adamopoulos A; Anastasiadis P
    Clin Exp Obstet Gynecol; 2001; 28(3):196-9. PubMed ID: 11530874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ultrasound-guided biopsy of non-palpable breast lesions: correlation with the results of fine-needle aspiration biopsy].
    Hilfiker PR; Caduff R; Pok-Lundquist J; Garzoli E; Marincek B; Kubik-Huch RA
    Gynakol Geburtshilfliche Rundsch; 2000; 40(1):41-6. PubMed ID: 10867495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electrical impedance scanning in the differentiation of suspicious breast lesions: comparison with mammography, ultrasound and histopathology].
    Fuchsjäger MH; Helbich TH; Ringl H; Funovics MA; Rudas M; Riedl C; Pfarl G
    Rofo; 2002 Dec; 174(12):1522-9. PubMed ID: 12471524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.